Jean‐François Rahier
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
- Genetics top 2%
- Inflammatory Bowel Disease 30
- Oncology top 5%
- COVID-19 and healthcare impacts 6
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 5
- Epidemiology top 5%
- Microscopic Colitis 15
-
- Eosinophilic Esophagitis 9
-
- Pregnancy and Medication Impact 6
- Co-authors
- Jean‐Frédéric ColombelFlávio SteinwurzGilaad G. KaplanRyan C. UngaroMichele Kissous-HuntMichael D. KappelmanJames D. LewisWalter Reinisch
- Cited by
- Infectious DiseasesGeneticsOncology
- Journals
- Journal of Crohn s and Colitis (17 papers)Inflammatory Bowel Diseases (6 papers)Gastroenterology (6 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Jean‐François Rahier
56 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Infectious Diseases 614
- Genetics 741
- Oncology 607
- Immunology 394
- Epidemiology 581
Countries citing papers authored by Jean‐François Rahier
This map shows the geographic impact of Jean‐François Rahier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Rahier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Rahier more than expected).
Fields of papers citing papers by Jean‐François Rahier
This network shows the impact of papers produced by Jean‐François Rahier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Rahier. The network helps show where Jean‐François Rahier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐François Rahier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 34 | |
| 8 | 2020 | 178 | |
| 9 | 2019 | 82 | |
| 10 | Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). | 2018 | 3 |
| 11 | 2018 | 5 | |
| 12 | 2016 | 18 | |
| 13 | 2016 | 79 | |
| 14 | 2014 | 2 | |
| 15 | 2013 | 46 | |
| 16 | 2013 | 74 | |
| 17 | 2012 | 5 | |
| 18 | 2010 | 130 | |
| 19 | 2007 | 2 | |
| 20 | 1994 | 11 |
About Jean‐François Rahier
Jean‐François Rahier is a scholar working on Genetics, Immunology and Epidemiology, having authored 60 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (15 papers), Eosinophilic Esophagitis (9 papers), COVID-19 Clinical Research Studies (7 papers), Pregnancy and Medication Impact (6 papers), COVID-19 and healthcare impacts (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (614 citations), Genetics (741 citations) and Oncology (607 citations). Jean‐François Rahier has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Jean‐Frédéric Colombel, Flávio Steinwurz, Gilaad G. Kaplan, Ryan C. Ungaro, Michele Kissous-Hunt, Michael D. Kappelman, James D. Lewis, Walter Reinisch, Erica J. Brenner and Richard B. Gearry. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Gastroenterology, Clinical Gastroenterology and Hepatology and Digestive Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.